Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications linking product attributes threshold pricing model how commercial thresholds can inform
… Share on: August 22, 2019 A Challenge of Real World Data: How to Assign Individuals to a Treatment Strategy When Their … because only people who live for a long time can receive treatment for a long time. A way to … cancer-specific mortality. We found that random assignment can be a valid alternative to cloning at baseline. The …
… as possible after diagnosis. Genomic/biomarker evaluations can not only help identify the best treatments for patients, … these data for research purposes, such as understanding how their product performs in real-world settings, identifying gaps in …
… longitudinal data methods- and particularly a joint mixed model for repeated measures, or MMRM – versus more commonly …
… are looking to implement health equity initiatives to inform their research and enhance data acquisition to address … in contemporary biomedical research and communications and how these best practices can strengthen demographic data-gathering methods. From …
… patient-reported outcome (PRO) data for oncology trials can present unique challenges. Join us as our panel of experts discuss these challenges and talk about how to overcome them. You’ll learn: The specific challenges … Why traditional statistical methods for clinical trials can lead to biased results when applied to oncology studies. …
… assessing the best methods to achieve study objectives and can support interpretation of results and examination of potential biases so that you can be confident in using your results to make informed …
… efficiency in observational studies . You’ll learn How to map the identifiability conditions of causal effects … in an observational study To identify the problems that can arise when eligibility, start of follow-up, and exposure assignment are not aligned How to improve the precision of the effect estimates when …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… and its recommendation for reimbursement for subsequent pricing negotiations. The aim of JCAs is to increase the … time to perform factual checking of the final report. How Are Companies Responding to Expected Challenges With … key payer-relevant endpoints and comparators in a product’s pivotal clinical trials, with submissions occurring …
… PRO drug labeling who understand these differences can use that knowledge to guide their PRO measurement … PRO-related endpoints in cancer clinical research? And how can these challenges be overcome? • What are the emerging …
… and RTI Health Solutions. Full details of this research can be found at PharmacoEconomics - Open, doi: … Solutions researchers below. For more information on how we can assist with your vaccine research needs, click here . …